"Otrimed Clinical Research offers cutting-edge, paid clinical trials to patients in the Northern Kentucky, greater Cincinnati, Ohio region. Our medical director, Dr. Pragya B Gupta, has been successfully practicing Pain Management in the Northern Kentucky and Cincinnati OH area since 2002. He has treated over 3500 patients and established Otrimed Clinical Research in 2012 to provide his patients access to the newest and most innovative treatment options available."

During the past decade, Otrimed Clinical Research conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Otrimed Clinical Research" #1 sponsor was "Medtronic Spinal and Biologics" with 1 trials, followed by "Mesoblast, Ltd." with 1 trials sponsored, "Neurana Pharmaceuticals, Inc." with 1 trials sponsored, "Orexo AB" with 1 trials sponsored and "Seikagaku Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Otrimed Clinical Research" #1 collaborator was "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Otrimed Clinical Research" are "Acute Pain" (1 trials), "Back Pain" (1 trials), "Back Spasm Upper Back" (1 trials), "Back Strain" (1 trials) and "Degenerative Disc Disease" (1 trials). Many other conditions were trialed in "Otrimed Clinical Research" in a lesser frequency.

Most popular intervention types in "Otrimed Clinical Research" are "Drug" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "MDT-15" (1 trials), "OXD01 digital therapy" (1 trials), "Rexlemestrocel-L" (1 trials) and "Rexlemestrocel-L + HA Mixture" (1 trials). Other intervention names were less common.

The vast majority of trials in "Otrimed Clinical Research" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Otrimed Clinical Research". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Otrimed Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Otrimed Clinical Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".